Back to the Virtual Exhibit Hall
| |||
Hi my name is Alexis Wetzel and I’m the Pennsylvania Representative for Epizyme. If you are interested in learning more about Epizyme and the work we do on behalf of patients, please reach out to me directly at awetzel@epizyme.com or 724-610-1565 To Chat with Alexis Date and Time: 2/19/2021, 11:30 AM (GMT-05:00) Eastern Standard Time (America/New_York) Click Here: https://engage.veeva.com/m.html?j=7229461866&pwd=916252 Oncology Account Account | “Epizyme, Inc. is a fully integrated biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through transformative epigenetic medicines. In addition to a robust research and discovery pipeline, Epizyme has one commercial oncology product and is exploring the treatment potential of this therapy in investigational clinical trials focused on other conditions. By focusing on the genetic drivers of disease, Epizyme works to match new medicines with the patients who need them. For more information, visit www.epizyme.com
| Follicular Lymphoma Infographic_Conventions_9.2020.pdf Epizyme Corporate Brochure_plain.pdf EpizymeNOW Program Summary and Instructions_DIGITAL 10.26.20.pdf |